113 Oral Lyophilized Powder(Beijing Haiyi Pharm)
113口服冻干粉（北京海一药业）
Report date: 2025/10/21 14:09:47
NME
Base Information
Drug Name113 Oral Lyophilized Powder(Beijing Haiyi Pharm)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Haiyi Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Haiyi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A